|Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D.||Exec. Chairman||177,26k||N/A||1952|
|Dr. Alvira Macanovic Ph.D.||CEO, Pres and VP of Operations, Regulatory Affairs & Quality Assurance||182,19k||N/A||N/A|
|Mr. Victor Hugo C.M.A., CPA||Chief Financial Officer||65,79k||N/A||1970|
|Mr. Hirotaka Katagiri||CTO & Bus. Devel. Division Director||N/A||N/A||N/A|
|Ms. Jessica Naman||Director of Marketing||N/A||N/A||N/A|
|Mr. Desmond Hirson||Consultant||N/A||N/A||N/A|
|Mr. Jim Graba||Application Specialist & Chief Trainer||N/A||N/A||N/A|
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.
VentriPoint Diagnostics Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.